Tin tức & Cập nhật
Xem bài viết Ung thư
Xem
Chỉ hiển thị Multimedia
Neoadjuvant chemo plus durvalumab improves survival in NSCLC
30 Apr 2025
bởiStephen Padilla
The addition of durvalumab to neoadjuvant chemotherapy with cisplatin and docetaxel results in better survival rates among patients with resectable nonsmall cell lung cancer (NSCLC), according to a study presented at ELCC 2025.
Neoadjuvant chemo plus durvalumab improves survival in NSCLC
30 Apr 2025
Anaemia in half, iron deficiency in fifth of HK patients with advanced prostate cancer
22 Apr 2025
bởiNatalia Reoutova
Anaemia affects 52.4 percent, while iron deficiency is present in 20.7 percent of Hong Kong patients with advanced prostate cancer (CaP), according to findings from a local cohort.
